Somatic Alterations of the SMAD-2 Gene in Human Colorectal Cancers
Author Information
Author(s): Y Takagi, H Koumura, M Futamura, S Aoki, K Yamaguchi, H Kida, H Tanemura, K Shimokawa, S Saji
Primary Institution: Gifu University School of Medicine
Hypothesis
The study aims to determine the clinical alterations and significance of mutations in the SMAD-2 gene in colorectal cancers.
Conclusion
The SMAD-2 gene may play a role as a candidate tumor-suppressor gene in a small fraction of colorectal cancers.
Supporting Evidence
- Only one missense mutation and two homozygous deletions of the SMAD-2 gene were detected in the 36 cancers.
- The SMAD-2 mutation was present in an early stage lesion.
- Alterations of MAD-related genes at 18q21 are involved in the pathogenesis of colon cancers.
Takeaway
Scientists looked at a gene called SMAD-2 in people with colon cancer and found some changes, but not many. This gene might help stop cancer from growing.
Methodology
Mutation analyses of the SMAD-2 gene were carried out on cDNA samples from 36 primary colorectal cancer specimens using PCR, SSCP, and DNA sequencing.
Limitations
The study only detected a low frequency of mutations in the SMAD-2 gene.
Participant Demographics
Japanese patients diagnosed with colorectal cancers.
Statistical Information
P-Value
0.0026
Statistical Significance
p=0.0026
Want to read the original?
Access the complete publication on the publisher's website